Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ahvaz Jundishapur University of Medical Sciences

Hodgkin’s lymphoma after 2-month infliximab therapy: case report

Saeidi, S. and Ahmadzadeh, A. and Rajaei, E. and Rahim, F. and Jazayeri, S. N. and Shahjahani, M. and Saki, N. (2015) Hodgkin’s lymphoma after 2-month infliximab therapy: case report. Comparative clinical pathology, 24 (4). pp. 911-914. ISSN 16185641 (ISSN)

Full text not available from this repository.
Official URL: https://www.scopus.com/inward/record.uri?eid=2-s2....

Abstract

Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the axial skeleton. Joint pain and stiffness as well as reduced spinal mobility are among the clinical symptoms of this disease. AS mostly affects younger males. TNF blocker drugs like infliximab are among the best treatments for AS, relieving many symptoms of the disease by neutralizing the effect of TNF. However, the use of these drugs may increase the risk of malignancies. In this research, a 23-year-old male with a history of AS was investigated, who was afflicted with Hodgkin’s lymphoma as a rare complication following infliximab administration. © 2014, Springer-Verlag London.

Item Type: Article
Keywords: Ankylosing spondylitis Hodgkin’s lymphoma Infliximab Rheumatoid arthritis TNF-α
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine, Health and Life Sciences
Depositing User: مهندس مهدی شریفی
Last Modified: 01 Jun 2018 11:31
URI: http://eprints.ajums.ac.ir/id/eprint/16297

Actions (login required)

View Item View Item